Abstract
The pharmacokinetic interaction between quinidine and digoxin in patients is well-known, in general requiring a dose reduction of digoxin in patients concomitantly treated with quinidine. Quinine, the diastereomer of quinidine, has not been as extensively studied in this respect. In addition to an interaction with the renal clearance of digoxin by quinidine, both diastereomers have been reported to inhibit the biliary clearance of digoxin in man. To further investigate the mechanisms of these hepatobiliary transport interactions at the cellular level, we compared the effects of quinidine and quinine, as well as of the calcium antagonist verapamil, on the uptake of digoxin and ouabain in isolated rat hepatocytes. Initial uptake rates of digoxin and ouabain were determined in the presence of various concentrations of quinine and quinidine. A concentration dependent inhibition of the cellular uptake of both cardiac glycosides by quinine and quinidine was found, quinine being a more potent inhibitor than quinidine. Our results indicate a stereoselective inhibition of the hepatocellular uptake by the two diastereomers quinidine and quinine, the latter being about equipotent to verapamil. This unequal inhibitory potency of the two ba...Continue Reading
References
Feb 4, 1978·British Medical Journal·G Ejvinsson
Dec 15, 1992·Biochemical Pharmacology·H SteenD K Meijer
Jan 1, 1992·Chirality·P le CorreR le Verge
Mar 1, 1991·Clinical Pharmacology and Therapeutics·A HedmanK Schenck-Gustafsson
Jan 1, 1990·Clinical Pharmacology and Therapeutics·A HedmanB Nilsson
Jan 1, 1989·Journal of Pharmacobio-dynamics·K OkudairaM Hanano
Jun 1, 1987·European Journal of Clinical Investigation·B AngelinK Schenck-Gustafsson
Aug 1, 1988·Biochemical Pharmacology·K OkudairaM Hanano
Dec 1, 1987·British Journal of Clinical Pharmacology·G W MihalyR A Smallwood
Nov 1, 1986·Clinical Pharmacology and Therapeutics·D A NottermanM M Reidenberg
Dec 1, 1969·The Journal of Cell Biology·M N Berry, D S Friend
Feb 1, 1981·British Journal of Clinical Pharmacology·K Schenck-Gustafsson, R Dahlqvist
Apr 1, 1980·British Journal of Clinical Pharmacology·R DahlqvistK Schenck-Gustafsson
Dec 8, 1994·Nature·D GründemannH Koepsell
Dec 20, 1996·The Journal of Biological Chemistry·A E BuschH Koepsell
Apr 18, 1997·The Journal of Biological Chemistry·D GründemannE Schömig
Mar 26, 1998·Journal of Hepatology·A Hedman, D K Meijer
Citations
Sep 7, 2002·Archives of Pharmacal Research·Dirk K F Meijer, Jessica E van Monffoort
Aug 8, 2001·Journal of Pharmacological and Toxicological Methods·P OlingaG M Groothuis
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Yoshihisa ShitaraYuichi Sugiyama
Oct 24, 2002·Biological & Pharmaceutical Bulletin·Kazuhiro WatanabeJuichi Sato
Jan 8, 2004·Biological & Pharmaceutical Bulletin·Kazuhiro WatanabeJuichi Sato
Oct 4, 2006·Biological & Pharmaceutical Bulletin·Koji SakanakaHitoshi Sasaki
Jul 27, 2011·Pharmacogenomics·Fabian Müller, Martin F Fromm
Apr 13, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·L Salphati, L Z Benet
Dec 15, 2015·The Journal of Pharmacology and Experimental Therapeutics·Atsushi KawaseMasahiro Iwaki
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H Lennernäs
Aug 27, 2003·Journal of Pharmacological Sciences·Keiji YamamotoToshifumi Watanabe
Oct 12, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Emi KimotoDavid B Duignan